03/13/2024
3:30 PM | Citius Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/03/2024
11:15 PM | Citius Pharmaceuticals (Filer)
| Form EFFECT | |
02/23/2024
3:23 PM | Citius Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
02/23/2024
3:18 PM | Citius Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/15/2024
7:45 AM | Citius Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
8:18 AM | Citius Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/31/2024
1:08 PM | BlackRock Inc. (Filed by)
Citius Pharmaceuticals (Subject)
| Form SC 13G | |
|
01/23/2024
3:05 PM | Citius Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/24/2023
6:53 AM | Citius Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/24/2023
6:58 AM | Citius Pharmaceuticals (Subject)
| Form 425 | |
10/12/2023
3:15 PM | Citius Pharmaceuticals (Issuer)
Mazur Leonard L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/12/2023
3:15 PM | Citius Pharmaceuticals (Issuer)
Dutia Suren G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/12/2023
3:15 PM | Bartushak Jaime (Reporting)
Citius Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/12/2023
3:15 PM | Citius Pharmaceuticals (Issuer)
MCGRATH DENNIS M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/12/2023
3:15 PM | Citius Pharmaceuticals (Issuer)
Holuka Eugene Myron (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/12/2023
3:15 PM | Citius Pharmaceuticals (Issuer)
HOLUBIAK MYRON Z (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/12/2023
3:15 PM | Citius Pharmaceuticals (Issuer)
Czuczman Myron (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/12/2023
3:15 PM | Citius Pharmaceuticals (Issuer)
Webb Carol (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/25/2023
3:30 PM | Citius Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/15/2023
3:30 PM | Citius Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/11/2023
8:53 AM | Citius Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/08/2023
7:40 AM | Citius Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/15/2023
8:25 AM | Citius Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/31/2023
3:15 PM | Citius Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/31/2023
3:15 PM | Citius Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/29/2023
3:15 PM | Citius Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/20/2023
3:05 PM | Citius Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/12/2023
3:15 PM | Citius Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/05/2023
3:15 PM | Citius Pharmaceuticals (Filer)
| Form 424B5 | |
